Background
The pathogenesis of the syphilis serofast status has not well established in people living with HIV (PLH). We conducted a study to evaluate possible predictors and outcome of serofast status.
Methods
Prospective cohort study of 348 episodes of syphilis in 175 PLH. Serofast status was defined as persistence of positive non-treponemal RPR titer after serological response to therapy (at least a 4-fold decline in the titer of RPR 12 months after treatment). Demographic and HIV-related data, RPR titer at diagnosis, time of response and outcome of serofast-diagnosed PLH were analyzed.
Results
At the first episode of syphilis, median age was 47 years, 99 were males and 95% had MSM as risk practice. Median time of HIV infection was 101 months and nadir CD4+ count of 303 cells/mcL. At diagnosis, late latent or unknown duration stage was observed in 51%, and median RPR titer was 1/32. By only considering those PLH with serological response at 12 months (132, 75%), 63 of them (51%) were identified as persistence of serofast status according to our definition. As it could be expected, serofast status was observed in the case of higher initial RPR titers (p=0.005), lower rate of serological response at the first determination (56% vs 35%; p=0.082), longer time of HIV infection (132 vs 84 months; p=0.013), and lower CD4/CD8 ratio at diagnosis (0.88 vs 1.52, p=0.07). Of note, time to indetectable and resolution of serofast state was shorter in subsequent syphilis episodes (p=0.02). In a Cox multivariate analysis, a shorter time of serological response at the first determination (Hazard ratio, HR, 0.89; p=0.034), a higher nadir CD4/CD8 ratio (HR 4.86; p=0.044), and a lower CD4/CD8 ratio at the time of diagnosis (HR 0.24; p=0.04) were associated with shorter time of serofast status. Indeed, 22 out of 63 serofast became indetectable during a median follow up of 35 months (3.6 person-years), decreasing to median RPR titer of 1/2 at the last determination, and without later increases of treponemal test in absence of reinfection.
Conclusions
This prospective study clarifies the factors associated with serofast status after a syphilis diagnosis. Importantly, serofast status was related to the intersection of serological presentation and immunological factors, with a trend to decrease progressively. Thus, this study ruled out the need of additional studies and interventions in this population.